TRPV2: A Cancer Biomarker and Potential Therapeutic Target
The Transient Receptor Potential Vanilloid type-2 (TRPV2) channel exhibits oncogenicity in different types of cancers. TRPV2 is implicated in signaling pathways that mediate cell survival, proliferation, and metastasis. In leukemia and bladder cancer, the oncogenic activity of TRPV2 was linked to al...
Main Authors: | Kodappully S. Siveen, Parveen B. Nizamuddin, Shahab Uddin, Mohamed Al-Thani, Michael Paul Frenneaux, Ibrahim A. Janahi, Martin Steinhoff, Fouad Azizi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2020/8892312 |
Similar Items
-
Curcumin-Mediated Apoptotic Cell Death in Papillary Thyroid Cancer and Cancer Stem-Like Cells through Targeting of the JAK/STAT3 Signaling Pathway
by: Abdul Q. Khan, et al.
Published: (2020-01-01) -
Dysregulated Phosphorylation of p53, Autophagy and Stemness Attributes the Mutant p53 Harboring Colon Cancer Cells Impaired Sensitivity to Oxaliplatin
by: Lubna Therachiyil, et al.
Published: (2020-08-01) -
Endothelial TRPV1 as an Emerging Molecular Target to Promote Therapeutic Angiogenesis
by: Sharon Negri, et al.
Published: (2020-05-01) -
Role of TRPV1 and TRPA1 Ion Channels in Inflammatory Bowel Diseases: Potential Therapeutic Targets?
by: Kata Csekő, et al.
Published: (2019-03-01) -
Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products
by: Kodappully S. Siveen, et al.
Published: (2018-02-01)